Involvement of autophagy in the beneficial effects of resveratrol in hepatic steatosis treatment. A comparison with energy restriction

2018 ◽  
Vol 9 (8) ◽  
pp. 4207-4215 ◽  
Author(s):  
I. Milton-Laskibar ◽  
L. Aguirre ◽  
U. Etxeberria ◽  
F. I. Milagro ◽  
J. A. Martínez ◽  
...  

Involvement of autophagy in the liver delipidating effects of resveratrol and energy restriction.

Author(s):  
Jukka Hintikka ◽  
Sanna Lensu ◽  
Elina Mäkinen ◽  
Sira Karvinen ◽  
Marjaana Honkanen ◽  
...  

We have shown that prebiotic xylo-oligosaccharides (XOS) increased beneficial gut microbiota (GM) and prevented high fat diet-induced hepatic steatosis, but the mechanisms associated with these effects are not clear. We studied whether XOS affects adipose tissue inflammation and insulin signaling, and whether the GM and fecal metabolome explain associated patterns. XOS was supplemented or not with high (HFD) or low (LFD) fat diet for 12 weeks in male Wistar rats (n = 10/group). Previously analyzed GM and fecal metabolites were biclustered to reduce data dimensionality and identify interpretable groups of co-occurring genera and metabolites. Based on our findings, biclustering provides a useful algorithmic method for capturing such joint signatures. On the HFD, XOS-supplemented rats showed lower number of adipose tissue crown-like structures, increased phosphorylation of AKT in liver and adipose tissue as well as lower expression of hepatic miRNAs. XOS-supplemented rats had more fecal glycine and less hypoxanthine, isovalerate, branched chain amino acids and aromatic amino acids. Several bacterial genera were associated with the metabolic signatures. In conclusion, the beneficial effects of XOS on hepatic steatosis involved decreased adipose tissue inflammation and likely improved insulin signaling, which were further associated with fecal metabolites and GM.


Author(s):  
Khalifa El-Dawy ◽  
Amany I. Ahmed ◽  
Samar I. Sharsher ◽  
Mohamed Metwally ◽  
Ahmed Hamed Arisha

2006 ◽  
Vol 0 (0) ◽  
pp. 061108012713001-??? ◽  
Author(s):  
Sanjaya K Satapathy ◽  
Puja Sakhuja ◽  
Veena Malhotra ◽  
Barjesh C Sharma ◽  
Shiv K Sarin

2020 ◽  
Vol 158 (6) ◽  
pp. S-1272
Author(s):  
Vincent L. Chen ◽  
Xiaomeng Du ◽  
Samuel K. Handelman ◽  
Elizabeth Speliotes

2014 ◽  
Vol 60 (1) ◽  
pp. S148-S149
Author(s):  
J. Wohlfahrt ◽  
A. Fettelschoss ◽  
T. Kündig ◽  
H. Hermanns ◽  
B. Müllhaupt ◽  
...  

Nutrients ◽  
2017 ◽  
Vol 9 (7) ◽  
pp. 737 ◽  
Author(s):  
Iñaki Milton-Laskibar ◽  
Leixuri Aguirre ◽  
Alfredo Fernández-Quintela ◽  
Anabela Rolo ◽  
João Soeiro Teodoro ◽  
...  

Nutrients ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 2991 ◽  
Author(s):  
Dicle Kargin ◽  
Laura Tomaino ◽  
Lluís Serra-Majem

The Mediterranean Diet (MD) is, culturally and historically, the nutritional pattern shared by people living in the olive-tree growing areas of the Mediterranean basin. It is of great importance for its potential preventive effect against cardiovascular diseases (CVDs). The PREvención con DIeta MEDiterránea (PREDIMED) study, a Spanish multicentre randomised controlled trial (RCT), was designed to assess the long-term effects of the MD, without any energy restriction, on the incidence of CVD in individuals at high cardiovascular (CV) risk. Since its inception, it gave a great contribution to the available literature on the issue. It is well known that, in the field of the health sciences, RCTs provide the best scientific evidence. Thus, the aim of the present review is to analyse the results of the RCTs performed within the frame of the PREDIMED study. Our findings showed that MD has beneficial effects in the primary prevention of CVDs, diabetes and in the management of metabolic syndrome.


Sign in / Sign up

Export Citation Format

Share Document